Zhang Financial LLC Biogen Inc. Transaction History

Zhang Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	SELL	$253.3 - $285.89 $19,757 - $22,299	-78 Reduced 7.73%	931 $239,000
Q2 2023 Jul 18, 2023	SELL	$275.25 - $318.06 $46,517 - $53,752	-169 Reduced 14.35%	1,009 $287,000
Q1 2023 May 10, 2023	BUY	$256.56 - $292.34 $19,755 - $22,510	77 Added 6.99%	1,178 $327,000
Q4 2022 May 17, 2023	SELL	$252.44 - $306.72 $19,437 - $23,617	-77 Reduced 6.54%	1,101 $304,000
Q4 2022 Jan 17, 2023	SELL	$252.44 - $306.72 $8,835 - $10,735	-35 Reduced 3.08%	1,101 $305,000

Q3 2022 Oct 18, 2022	BUY	$194.69 - $268.46 $221,167 - $304,970	1,136 New	1,136 $304,000
Q1 2022 Apr 21, 2022	SELL	$193.77 - $244.14 $276,316 - $348,143	-1,426 Closed	0 $0
Q3 2021 Oct 20, 2021	BUY	$282.99 - $369.05 $403,543 - $526,265	1,426 New	1,426 $404,000

1,077

131M

3.77M

2.31M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $24.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Zhang Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Zhang Financial LLC with notifications on news.